about
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Read More
4.19
-0.26
(-5.84%)
63,530
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Exicure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..